Royce & Associates LP Sells 4,863 Shares of Premier, Inc. (NASDAQ:PINC)

Royce & Associates LP trimmed its position in shares of Premier, Inc. (NASDAQ:PINC) by 22.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,430 shares of the company’s stock after selling 4,863 shares during the period. Royce & Associates LP’s holdings in Premier were worth $348,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of PINC. Brandes Investment Partners LP raised its stake in shares of Premier by 123.1% during the fourth quarter. Brandes Investment Partners LP now owns 842,326 shares of the company’s stock valued at $17,857,000 after acquiring an additional 464,710 shares during the last quarter. Assenagon Asset Management S.A. raised its stake in shares of Premier by 109.8% during the fourth quarter. Assenagon Asset Management S.A. now owns 468,524 shares of the company’s stock valued at $9,933,000 after acquiring an additional 245,239 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Premier by 5.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,741,784 shares of the company’s stock worth $34,836,000 after buying an additional 97,458 shares in the last quarter. Quantinno Capital Management LP raised its stake in Premier by 310.3% in the third quarter. Quantinno Capital Management LP now owns 115,833 shares of the company’s stock worth $2,317,000 after buying an additional 87,601 shares in the last quarter. Finally, Jackson Creek Investment Advisors LLC bought a new position in Premier in the fourth quarter worth about $1,570,000. 74.41% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Helen M. Boudreau sold 2,500 shares of the stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $21.42, for a total transaction of $53,550.00. Following the sale, the director now owns 20,668 shares in the company, valued at $442,708.56. This represents a 10.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 0.96% of the company’s stock.

Premier Stock Performance

Shares of PINC opened at $18.55 on Friday. The stock has a market cap of $1.69 billion, a PE ratio of -185.48 and a beta of 0.39. Premier, Inc. has a fifty-two week low of $17.23 and a fifty-two week high of $23.56. The firm’s 50-day simple moving average is $19.60 and its two-hundred day simple moving average is $20.52.

Premier Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Saturday, March 15th. Stockholders of record on Saturday, March 1st were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.53%. The ex-dividend date was Friday, February 28th. Premier’s payout ratio is -840.00%.

Wall Street Analysts Forecast Growth

PINC has been the subject of a number of research reports. Piper Sandler decreased their price target on shares of Premier from $21.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Robert W. Baird decreased their price target on shares of Premier from $20.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Finally, Canaccord Genuity Group decreased their price target on shares of Premier from $21.00 to $19.00 and set a “hold” rating for the company in a research note on Wednesday, February 5th. Eight equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, Premier has a consensus rating of “Hold” and a consensus price target of $20.17.

Premier Profile

Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.